Stanley G. Rockson, MD

Clinical Focus

• Lymphatic Diseases
• Cardiology (Heart)
• Cardiology (Heart), Preventive
• Cardiovascular Disease

Administrative Appointments

• Allan and Tina Neill Professor of Lymphatic Research and Medicine, Stanford University (2008 - present)
• Chief of Consultative Cardiology, Stanford University (1997 - present)
• Director, Stanford Center for Lymphatic and Venous Disorders, Stanford University (2000 - present)
• Chair, Scientific Advisory Committee, Lymphatic Research Foundation (1999 - present)
• Editor-in-Chief, Lymphatic Research and Biology (2002 - present)

Honors and Awards

• Pioneer Award, Lymphatic Research Foundation (2009)
• E. William Hancock Cardiovascular Medicine Teaching Award, Stanford University (2008)
• Franklin G. Ebaugh Jr. Award for Mentoring Medical Students, Stanford University (2008)
• Chief Residents' Teaching Award, Department of Medicine, Stanford University (2003)
• Teaching Award in Cardiology, Department of Medicine, Stanford University (2000)

Professional Education

Graduate & Fellowship Program Affiliations

• Medicine
• Cardiovascular Medicine

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

Biomarker identification in lymphatic vascular disease

Drug therapy to reverse lymphatic disease - animal model and pilot human studies

Lymphangiogenesis in Acute and Chronic Experimental Lymphedema

Lymphangiogenesis in Lymphatic Insufficiency: Lymphatic Endothelial and Inflammatory RNA Expression Patterns

Genome-wide Transcriptional Profiling for the Study of Lymphedema Pathobiology,Cellular Signaling Mechanisms and Mechanisms of Therapeutic Lymphangiogenesis

Peripheral Arterial Disease and Critical Limb Ischemia

Randomized trials for the intracoronary infusion of VEGF (vascular endothelial growth factor) to treat advanced coronary artery disease.

Lipid-lowering outcomes trials in coronary and peripheral atherosclerosis.

Clinical outcomes trials to assess therapeutic interventions in post-mastectomy and other forms of lymphedema.

Clinical Trials

• Lymphedema Drug/Placebo Prevention trial Recruiting
• Lymphedema Early Detection Trial Recruiting
• Lymphedema: Punch Biopsy-Drug Study Recruiting
• National Breast Cancer and Lymphedema Registry Recruiting
• National Lymphatic Disease and Lymphedema Registry Recruiting

Publications

• Reflections on a Decade of Lymphatic Research and Biology. Rockson SG, Lymphat Res Biol. 2012; 10 (1): 1
• Update on the Biology and Treatment of Lymphedema. Rockson SG, Curr Treat Options Cardiovasc Med. 2012
• Animal models for the mechanistic study of systemic lymphangiomatosis. Rockson SG, Lymphat Res Biol. 2011; 9 (4): 195-9
• Lack of Significant Interactions Between Clopidogrel and Proton Pump Inhibitor Therapy: Meta-Analysis of Existing Literature. Gerson LB, McMahon D, Olkin I, Stave C, Rockson SG. Dig Dis Sci. 2011
• Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Avraham T, Daluvoy S, Zampell J, Yan A, Haviv YS, Rockson SG, Mehrara BJ. Am J Pathol. 2010; 177 (6): 3202-14